Westiellamide | CAS#131998-54-4 | cyclic peptide

MedKoo Cat#: 462093 | Name: Westiellamide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Westiellamide is a a bistratamide-related cyclic peptide from the blue-green alga westiellopsis prolifica.

Chemical Structure

Westiellamide

CAS#131998-54-4

Theoretical Analysis

MedKoo Cat#: 462093

Name: Westiellamide

CAS#: 131998-54-4

Chemical Formula: C27H42N6O6

Exact Mass: 546.3166

Molecular Weight: 546.67

Elemental Analysis: C, 59.32; H, 7.74; N, 15.37; O, 17.56

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Westiellamide

IUPAC/Chemical Name

6,13,20-Trioxa-3,10,17,22,23,24-hexaazatetracyclo(17.2.1.1(5,8).1(12,15))tetracosa-5(24),12(23),19(22)-triene-2,9,16-trione, 7,14,21-trimethyl-4,11,18-tris(1-methylethyl)-, (1S-(1R*,4R*,7S*,8R*,11R*,14S*,15R*,18R*,21S*))-

InChi Key

MIDTUAMKJJDHAR-YAWPOEEYSA-N

InChi Code

InChI=1S/C27H42N6O6/c1-10(2)16-25-31-20(13(7)37-25)23(35)29-18(12(5)6)27-33-21(15(9)39-27)24(36)30-17(11(3)4)26-32-19(14(8)38-26)22(34)28-16/h10-21H,1-9H3,(H,28,34)(H,29,35)(H,30,36)/t13-,14-,15-,16+,17+,18+,19+,20+,21+/m1/s1

SMILES Code

O=C(N[C@@H](C(C)C)C1=N[C@@](C(N[C@@H](C(C)C)C2=N[C@@](C(N[C@H]3C(C)C)=O)([H])[C@@H](C)O2)=O)([H])[C@@H](C)O1)[C@]4([H])[C@@H](C)OC3=N4

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 546.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Mild Hypothermia Decreases Fentanyl and Midazolam Steady-State clearance in a Rat Model of Cardiac Arrest Philip E. Empey, Tricia M. Miller, Ashley H. Philbrick, John Melick, Patrick M. Kochanek, Samuel M. Poloyac Crit Care Med. Author manuscript; available in PMC 2013 Apr 1.Published in final edited form as: Crit Care Med. 2012 Apr; 40(4): 1221–1228. doi: 10.1097/CCM.0b013e31823779f9 PMCID: PMC3307845 2: Thiazole and Oxazole Alkaloids: Isolation and Synthesis Danilo Davyt, Gloria Serra Mar Drugs. 2010; 8(11): 2755–2780. Published online 2010 Nov 5. doi: 10.3390/md8112755 PMCID: PMC2996175 3: Bistratamides M and N, Oxazole-Thiazole Containing Cyclic Hexapeptides Isolated from Lissoclinum bistratum Interaction of Zinc (II) with Bistratamide K Carlos Urda, Rogelio Fernández, Jaime Rodríguez, Marta Pérez, Carlos Jiménez, Carmen Cuevas Mar Drugs. 2017 Jul; 15(7): 209. Published online 2017 Jul 1. doi: 10.3390/md15070209 PMCID: PMC5532651 4: Natural Products from Cyanobacteria: Focus on Beneficial Activities Justine Demay, Cécile Bernard, Anita Reinhardt, Benjamin Marie Mar Drugs. 2019 Jun; 17(6): 320. Published online 2019 May 30. doi: 10.3390/md17060320 PMCID: PMC6627551 5: Indole Alkaloids of the Stigonematales (Cyanophyta): Chemical Diversity, Biosynthesis and Biological Activity Katherine Walton, John P. Berry Mar Drugs. 2016 Apr; 14(4): 73. Published online 2016 Apr 6. doi: 10.3390/md14040073 PMCID: PMC4849077 6: Genome mining for natural product biosynthetic gene clusters in the Subsection V cyanobacteria Melinda L. Micallef, Paul M. D’Agostino, Deepti Sharma, Rajesh Viswanathan, Michelle C. Moffitt BMC Genomics. 2015; 16(1): 669. Published online 2015 Sep 3. doi: 10.1186/s12864-015-1855-z PMCID: PMC4558948 7: Naturally Occurring Oxazole-Containing Peptides Jessica T. Mhlongo, Edikarlos Brasil, Beatriz G. de la Torre, Fernando Albericio Mar Drugs. 2020 Apr; 18(4): 203. Published online 2020 Apr 10. doi: 10.3390/md18040203 PMCID: PMC7231064 8: Marine Natural Product Peptides with Therapeutic Potential: Chemistry, Biosynthesis, and Pharmacology Vedanjali Gogineni, Mark T. Hamann Biochim Biophys Acta. Author manuscript; available in PMC 2019 Jan 1.Published in final edited form as: Biochim Biophys Acta. 2018 Jan; 1862(1): 81–196. Published online 2017 Aug 24. doi: 10.1016/j.bbagen.2017.08.014 PMCID: PMC5918664 9: Cyanobactins—ribosomal cyclic peptides produced by cyanobacteria Kaarina Sivonen, Niina Leikoski, David P. Fewer, Jouni Jokela Appl Microbiol Biotechnol. 2010 May; 86(5): 1213–1225. Published online 2010 Feb 27. doi: 10.1007/s00253-010-2482-x PMCID: PMC2854353 10: Fluorocyclisation via I(I)/I(III) catalysis: a concise route to fluorinated oxazolines Felix Scheidt, Christian Thiehoff, Gülay Yilmaz, Stephanie Meyer, Constantin G Daniliuc, Gerald Kehr, Ryan Gilmour Beilstein J Org Chem. 2018; 14: 1021–1027. Published online 2018 May 9. doi: 10.3762/bjoc.14.88 PMCID: PMC6009682